Advocacy intelligence hub — real-time data for patient organizations
Regeneron Pharmaceuticals — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andrea M Haqq, MD, M.D
University of Alberta
📍 DURHAM, NC
Michael Freemark, MD
Duke University
📍 DURHAM, NC
Marie-Ange DELRUE, MD
University Hospital Bordeaux, France
Béatrice DUBERN, MD, PhD
Assistance Publique - Hôpitaux de Paris
Emmanuel DISSE, Pr
Hospices Civils de Lyon / Service Nutrition Diabétologie Endocrinologie